Something I’ve come to notice is that both the approaches to treatment, and also the treatments available, can vary fairly significantly by country. There can also be considerations around access to care (eg health insurance in the US, NHS in the UK, Medicare in Australia) which may need to be factored in.
I wonder hence if it might be helpful to recommend including your location in forum signatures. Just country-level is probably sufficient given most folk would likely consider some domestic travel for treatments (although US patients may want to include their state as well).
Male 37 years; Melbourne, Australia
10/2018 Dx: 3.5 cm rectal adenocarcinoma, 10 cm from verge. Well/mod diff (G1-2), T3bN1bM1a.
3 enlarged local lymph nodes and 4 liver lesions.
MSS, MMR-proficient, mutated in NRAS (G13R).
CEA: Oct-18 = 12; Nov-18 = 14, Mar-19 = 2.4
11/18 - 6 cycles neoadjuvant FOLFOX
12/18 - DVT, started clexane
3/19 - Liver resection, R0
4-5/19 - Long-course pelvic chemoradiation (45 Gy w/ Xeloda)
07/19 - Planned restaging scans and ULAR w temp ileo